2022 annual financial data
Arbutus Biopharma 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was -90.61%.
Operating income was -65,456,000 USD and net income was -69,456,000 USD.
Operating cash flow was -35,356,000 USD.
Get free Arbutus Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 39,019,000 USD
- Operating income
- -65,456,000 USD
- Net income
- -69,456,000 USD
- Operating cash flow
- -35,356,000 USD